Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the A Phase Iii, Randomized, Two-Armed, Double-Blind, Parallel, Active Controlled, and Non-Inferiority Clinical Trial to Compare Efficacy and Safety of Biosimilar Adalimumab (Cinnora®) to the Reference Product (Humira®) in Patients With Active Rheumatoid Arthritis
Morteza Samadi-Foroushani
Morteza Samadi-Foroushani

Professor of Medical Immunology

Department of Immunology, School of Medicine

Isfahan University of Medical Sciences

All Documents
12. Association Between Interleukin-23 Receptor R381q Gene Polymorphism and Asthma, Iranian Journal of Allergy, Asthma and Immunology (2015)